PL328309A1 - Thermally stabilised contrast medium - Google Patents

Thermally stabilised contrast medium

Info

Publication number
PL328309A1
PL328309A1 PL32830997A PL32830997A PL328309A1 PL 328309 A1 PL328309 A1 PL 328309A1 PL 32830997 A PL32830997 A PL 32830997A PL 32830997 A PL32830997 A PL 32830997A PL 328309 A1 PL328309 A1 PL 328309A1
Authority
PL
Poland
Prior art keywords
contrast medium
thermally stabilised
stabilised contrast
thermally
medium
Prior art date
Application number
PL32830997A
Inventor
Marit Swaerd-Nordmo
Per Helge Gulliksen
Jorunn Undheim Braenden
Anne Kjersti Fahlvik
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9603466.5A priority Critical patent/GB9603466D0/en
Priority to GBGB9611894.8A priority patent/GB9611894D0/en
Priority to GBGB9624919.8A priority patent/GB9624919D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Priority to PCT/GB1997/000458 priority patent/WO1997029782A1/en
Publication of PL328309A1 publication Critical patent/PL328309A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
PL32830997A 1996-02-19 1997-02-19 Thermally stabilised contrast medium PL328309A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9603466.5A GB9603466D0 (en) 1996-02-19 1996-02-19 Improvements in or relating to contrast agents
GBGB9611894.8A GB9611894D0 (en) 1996-06-07 1996-06-07 Improvements in or relating to contrast agents
GBGB9624919.8A GB9624919D0 (en) 1996-11-29 1996-11-29 Product
PCT/GB1997/000458 WO1997029782A1 (en) 1996-02-19 1997-02-19 Thermally stabilized contrast agent

Publications (1)

Publication Number Publication Date
PL328309A1 true PL328309A1 (en) 1999-01-18

Family

ID=27268136

Family Applications (1)

Application Number Title Priority Date Filing Date
PL32830997A PL328309A1 (en) 1996-02-19 1997-02-19 Thermally stabilised contrast medium

Country Status (18)

Country Link
EP (1) EP0885016B1 (en)
JP (1) JP4250747B2 (en)
KR (1) KR100501863B1 (en)
CN (1) CN1092988C (en)
AT (1) AT237362T (en)
AU (1) AU722735B2 (en)
CA (1) CA2246778A1 (en)
CZ (1) CZ262698A3 (en)
DE (2) DE69720979D1 (en)
EA (1) EA000900B1 (en)
EE (1) EE9800248A (en)
ES (1) ES2197331T3 (en)
HU (1) HU9900812A3 (en)
IL (1) IL125800D0 (en)
NO (1) NO313815B1 (en)
NZ (1) NZ331372A (en)
PL (1) PL328309A1 (en)
WO (1) WO1997029782A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100593873B1 (en) 1996-08-02 2006-07-03 지이 헬스케어 에이에스 Improvements in or relating to contrast agent
GB9717542D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Process
KR20030023697A (en) * 2000-07-13 2003-03-19 다이이찌 세이야꾸 가부시기가이샤 Pharmaceutical compositions containing DDS compounds
US6793626B2 (en) 2001-01-17 2004-09-21 Fuji Photo Film Co., Ltd. Ultrasonic scatterer, ultrasonic imaging method and ultrasonic imaging apparatus
DE60111917T2 (en) * 2001-01-31 2006-04-20 Bracco International B.V. Lyophilisable contrast agent containing gas-filled microbubbles
JP4748564B2 (en) 2002-11-29 2011-08-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ Ultrasonic trigger method
MXPA05007730A (en) 2003-02-04 2006-01-31 Bracco Int Bv Ultrasound contrast agents and process for the preparation thereof.
ES2531732T3 (en) 2003-12-22 2015-03-18 Bracco Suisse Sa Gas filled microvesicle assembly for contrast imaging
AU2005273865B2 (en) 2004-08-18 2011-02-24 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
WO2006076826A1 (en) * 2005-01-18 2006-07-27 Institute Of Pharmacology Toxicology, Academy Of Military Medical Sciences An ultrasonic contrast composition having phospholipid as film-former and the preparation method thereof
US9446156B2 (en) 2006-09-05 2016-09-20 Bracco Suisse S.A. Gas-filled microvesicles with polymer-modified lipids
US8293214B2 (en) 2006-12-19 2012-10-23 Bracco Suisse S.A. Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds
WO2009043468A2 (en) 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of corticotropin-releasing factor as a therapeutic agent
WO2009040030A1 (en) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
JP2010539001A (en) 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト Use of secretin and optional urodilatin as a therapeutic agent
WO2009043467A1 (en) 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag U e of urocortin and corticotropin-releasing fact r as therapeutic agents
WO2009040017A2 (en) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009033786A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
KR20100058551A (en) 2007-09-11 2010-06-03 몬도바이오테크 래보래토리즈 아게 Use of a peptide as a therapeutic agent
WO2009033763A1 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Nafarelin and carboxymethyl-phe-leu as therapeutic agents
EP2190450A2 (en) 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
WO2009046823A1 (en) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Exendin-3 and apelin-12 for therapeutic applications
US20100204110A1 (en) 2007-09-11 2010-08-12 Dorian Bevec Use of a peptide as a therapeutic agent
JP2010539010A (en) 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト Use of deslorelin and mastoparan as therapeutic agents
EP2346532A2 (en) 2008-10-07 2011-07-27 Bracco Suisse SA Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same
CN101649293B (en) 2009-09-02 2012-07-18 中国农业大学 Microbial freezing drying protective agent and application thereof
CN103079599B (en) 2010-08-09 2017-05-10 博莱科瑞士股份有限公司 Targeted gas-filled microvesicles
EP2426202A1 (en) 2010-09-03 2012-03-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Kinases as targets for anti-diabetic therapy
EP2654788B1 (en) 2010-12-24 2018-03-14 Bracco Suisse SA Gas-filled microvesicles for use as vaccine
DK2768484T3 (en) 2011-10-21 2019-10-07 Jazz Pharmaceuticals Res Llc Lyophilized liposomes
EP2589383A1 (en) 2011-11-06 2013-05-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin FKBP subtype-specific rapamycin analogue for use in treatment of diseases
GB201405735D0 (en) * 2014-03-31 2014-05-14 Ge Healthcare As Ultrasound precursor preparation method
EP3020813A1 (en) 2014-11-16 2016-05-18 Neurovision Pharma GmbH Antisense-oligonucleotides as inhibitors of TGF-R signaling

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US4642903A (en) * 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
JPH06211645A (en) * 1993-01-14 1994-08-02 Mitsubishi Kasei Corp Lyophilized liposome preparation

Also Published As

Publication number Publication date
CA2246778A1 (en) 1997-08-21
IL125800D0 (en) 1999-04-11
EP0885016A1 (en) 1998-12-23
WO1997029782A1 (en) 1997-08-21
CN1213971A (en) 1999-04-14
DE69720979T2 (en) 2004-02-26
HU9900812A3 (en) 1999-11-29
NO983584D0 (en) 1998-08-05
AT237362T (en) 2003-05-15
KR100501863B1 (en) 2005-09-27
KR19990082670A (en) 1999-11-25
JP4250747B2 (en) 2009-04-08
NO983584L (en) 1998-10-16
JP2000506122A (en) 2000-05-23
CZ262698A3 (en) 1999-03-17
EA199800739A1 (en) 1999-02-25
EE9800248A (en) 1999-02-15
EA000900B1 (en) 2000-06-26
CN1092988C (en) 2002-10-23
NO313815B1 (en) 2002-12-09
EP0885016B1 (en) 2003-04-16
HU9900812A2 (en) 1999-07-28
ES2197331T3 (en) 2004-01-01
DE69720979D1 (en) 2003-05-22
NZ331372A (en) 2000-01-28
AU722735B2 (en) 2000-08-10
AU1805197A (en) 1997-09-02

Similar Documents

Publication Publication Date Title
DE69826273D1 (en) Knochentransplantat-composite und -spacern
DE69800640D1 (en) Pegylationsverfahren
DE69826254D1 (en) Modulare humerusprothese
DE69807872D1 (en) Thermoplastisches polyetherurethan
DE69709184D1 (en) Knöchel-fuss orthese
DE69804946D1 (en) Opthalmische formmasse
DE69831868D1 (en) Antithrombosemittel
DE69808438D1 (en) Hüftprothese
GB2330671B (en) Media manager
DE69809754D1 (en) Substituierte 6-phenylphenanthridine
GB2322463B (en) Media selecting device
DE69833428D1 (en) Medium dentable cap
DE69816992D1 (en) Benzimidazolderivate
DE69840963D1 (en) Thermale therapievorrichtung
GB2289442B (en) Thermal printer
DE69835201D1 (en) Neoglycoproteine
DE69827940D1 (en) Thiarylsulfonamid-hydroxamsäurederivate
DE69837702D1 (en) Lastsensor
GB2330139B (en) Polymerizable chiral compounds,and their use
DE69838100D1 (en) Gefässprothese
DE69837398D1 (en) Festphasenextrationsplatte
DE69813225D1 (en) Blockcopolymere
DE69827236D1 (en) Matrix-metalloproteinase-hemmer
DE69830051D1 (en) Endotrachealtubus
DE69737592D1 (en) Medium against juckreiz